pyrrolobenzodiazepines (Napo)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Namepyrrolobenzodiazepines (Napo)
Drug Alias Namepyrrolobenzodiazepines (IndUS)NSC-723734NSC-726260
ClassificationSmall molecules
Mechanisms of ActionGamma-aminobutyric acid A receptor modulatorsDNA intercalators
TargetsGamma-aminobutyric acid A receptorDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIndUS Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIndUS Pharmaceuticals IncNapo Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A